glp-1 injections monroe Puerto Rico leads U.S. growth in GLP-1 prescriptions in 2025 GLP-1 Doctor-Managed Weight Loss Marlboro,

doi: 10.1186/s12902-021-00733-6 58 YaziciDSunbulMYasarMDeyneliOYavuzD

*Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality

Therefore, many individuals supplement their coverage with a Medigap policy and a separate Part D plan for prescription drugs to manage potential expenses

Aronne LJ, et al

Both have shown promising effects on weight reduction and metabolic improvement

Patients carrying variants in these genes may have significantly higher weight regain risk after stopping semaglutide, meaning longer-term or indefinite therapy could be medically appropriate